Are You Aware Of Risperdal Gynecomastia Lawsuit?
Risperdal has been strongly linked causing young boys to develop female breast tissue—a condition known as gynecomastia. As a result, thousands of the victims have filed for lawsuits against manufacturer Johnson & Johnson. The medication, made by Johnson & Johnson/Janssen Pharmaceuticals, was FDA-approved for use by children and adolescents in 2006. However, it promoted the drug for young people years prior to its approval for use in children, and it lead to serious and devastating effects. The main concern Gynecomastia stems from a hormone imbalance and can result in the growth of male breasts and significant increase in the weight. It is has been studied by the experts how Risperdal may cause gynecomastia in some young male users because it increases levels of the hormone prolactin, which stimulates female breast development and at times even lactation. Risperdal Inappropriate Marketing Accusations In addition to the health side effect associated with Risperdal